Internal Medicine · Norfolk, VA
NPI
1053653899
Since 2013
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6206 N Military Hwy Ste H
Norfolk, VA, 23518
Phone (757) 271-5282
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
16,499 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Brian McCarthy prescribed most often to Medicare patients was Rosuvastatin Calcium, with 918 prescriptions and refills. In total Brian McCarthy wrote 16,499 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 918 | 921 | 56 | $52K |
| Amlodipine Besylate Generic | 666 | 668 | 59 | $15K |
| Atorvastatin Calcium Generic | 560 | 562 | 43 | $23K |
| Trazodone Hcl Generic | 539 | 541 | 39 | $8,867 |
| Duloxetine Hcl Generic | 453 | 454 | 23 | $21K |
| Furosemide Generic | 427 | 428 | 35 | $4,636 |
| Tamsulosin Hcl Generic | 420 | 421 | 22 | $16K |
| Omeprazole Generic | 379 | 380 | 30 | $16K |
| Escitalopram Oxalate Generic | 361 | 362 | 23 | $11K |
| Famotidine Generic | 351 | 352 | 26 | $9,369 |
| Carvedilol Generic | 348 | 349 | 32 | $12K |
| Metoprolol Succinate Generic | 331 | 332 | 21 | $5,223 |
| Sertraline Hcl Generic | 322 | 324 | 33 | $9,971 |
| Memantine Hcl Generic | 307 | 308 | 28 | $25K |
| Eliquis Apixaban | 290 | 290 | 21 | $98K |
Brand drugs: 1,594 claims; generic drugs: 14,870 claims; opioid claims: 77.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Brian McCarthy were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.